Dr Lucy Farrimond
Contact information
Research groups
Colleges
Lucy Farrimond
Academic Clinical Lecturer
I am an Academic Clinical Lecturer in NDCN and Honorary Neurology Registrar for Oxford University Hospitals NHS Foundation Trust. My research takes place within the Oxford Motor Neuron Disease Centre. I have a specific interest in mechanisms of motor neuron degeneration in motor neuron disease, also known as amyotrophic lateral sclerosis (ALS).
After qualifying in medicine (BM BCh) with distinction from the University of Oxford in 2012, I was awarded an Academic Foundation post in Oxford where I first joined Professor Kevin Talbot’s research group studying mouse models of ALS. I subsequently gained an NIHR Academic Clinical Fellowship in Neurology where I continued this work alongside clinical training in acute medicine and neurology. I recently completed a Wellcome Trust Clinical Research Fellowship applying optogenetics to induced pluripotent stem cells from ALS patients to study activity-dependent mechanisms of motor neuron degeneration in C9ORF72 associated ALS, the commonest genetic subtype.
I am now continuing my research with an NIHR Clinical Lectureship, with an ongoing focus on the role of motor neuron activity in ALS models and patients.
Recent publications
-
C9orf72-ALS human iPSC microglia are pro-inflammatory and toxic to co-cultured motor neurons via MMP9
Journal article
Vahsen BF. et al, (2023), Nature Communications, 14
-
Advantages of routine next‐generation sequencing over standard genetic testing in the amyotrophic lateral sclerosis clinic
Journal article
Scaber J. et al, (2023), European Journal of Neurology
-
Human iPSC co-culture model to investigate the interaction between microglia and motor neurons
Journal article
Vahsen BF. et al, (2022), Scientific Reports, 12
-
A case of SOD1 deficiency: implications for clinical trials.
Journal article
Farrimond L. and Talbot K., (2022), Brain
-
Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain
Journal article
Thompson AG. et al, (2022), Brain Communications, 4